Wednesday, January 27, 2016

Radius Health Announces Clinical Collaboration With a Leading Pharmaceutical Company to Evaluate RAD1901 Combination Regimens in Advanced Breast Cancer

… in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal … for hormone-driven, or hormone-resistant, metastatic breast cancer. RAD1901 is currently being investigated … overcome endocrine resistance in metastatic breast cancer. RAD1901 is also being evaluated …

No comments:

Post a Comment